A detailed history of Versor Investments LP transactions in Artivion, Inc. stock. As of the latest transaction made, Versor Investments LP holds 15,962 shares of AORT stock, worth $744,148. This represents 0.14% of its overall portfolio holdings.

Number of Shares
15,962
Holding current value
$744,148
% of portfolio
0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$30.29 - $44.83 $483,488 - $715,576
15,962 New
15,962 $675,000
Q1 2024

May 13, 2024

BUY
$16.7 - $21.63 $175,350 - $227,115
10,500 New
10,500 $222,000
Q1 2023

May 05, 2023

SELL
$11.74 - $14.12 $35,220 - $42,360
-3,000 Reduced 16.76%
14,900 $195,000
Q4 2022

Jan 30, 2023

BUY
$10.01 - $13.9 $179,179 - $248,810
17,900 New
17,900 $216,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.88B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.